179 related articles for article (PubMed ID: 30918117)
1. Increased serum/plasma fibroblast growth factor 21 in type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang YS; Ye J; Cao YH; Zhang R; Liu Y; Zhang SW; Dai W; Zhang Q
Postgrad Med J; 2019 Mar; 95(1121):134-139. PubMed ID: 30918117
[TBL] [Abstract][Full Text] [Related]
2. Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis.
Liu H; He X; Deng XY; Yan JL
BMC Musculoskelet Disord; 2023 Jun; 24(1):533. PubMed ID: 37386374
[TBL] [Abstract][Full Text] [Related]
3. Fıbroblast growth factor 21 and ıts relatıonshıp wıth ınsulın sensıtıvıty ın fırst-degree relatıves of patıents wıth type 2 dıabetes mellıtus.
Ors D; Eroglu Altinova A; Yalçın MM; Gulbahar O; Akturk M; Arslan M; Balos Toruner F
Endokrynol Pol; 2016; 67(3):260-4. PubMed ID: 26884286
[TBL] [Abstract][Full Text] [Related]
4. Association of circulating cystatin C levels with type 2 diabetes mellitus: a systematic review and meta-analysis.
Ma CC; Duan CC; Huang RC; Tang HQ
Arch Med Sci; 2020; 16(3):648-656. PubMed ID: 32399114
[TBL] [Abstract][Full Text] [Related]
5. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
Wang P; Li S; Liu LN; Lv TT; Li XM; Li XP; Pan HF
Clin Rheumatol; 2017 Oct; 36(10):2193-2200. PubMed ID: 28698901
[TBL] [Abstract][Full Text] [Related]
6. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the levels of serum fibroblast growth factor 19 and metabolic factors in obese and normal weight subjects with and without type 2 diabetes mellitus: a case-control study.
Razmi H; Tarighat-Esfanjani A; Payahoo L; Mobasseri M; Amirpour M; Mirzaei E; Ghoreishi Z
Horm Mol Biol Clin Investig; 2021 Feb; 42(1):11-17. PubMed ID: 33544512
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome.
Barutcuoglu B; Basol G; Cakir Y; Cetinkalp S; Parildar Z; Kabaroglu C; Ozmen D; Mutaf I; Bayindir O
Ann Clin Lab Sci; 2011; 41(4):390-6. PubMed ID: 22166511
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: a systematic review and meta-analysis.
Wang P; Lv TT; Guan SY; Li HM; Leng RX; Zou YF; Pan HF
Postgrad Med; 2017 Jan; 129(1):126-132. PubMed ID: 27666289
[TBL] [Abstract][Full Text] [Related]
10. Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.
Fan H; Sun X; Zhang H; Liu J; Zhang P; Xu Y; Pan Q; Wang G
Diabetes Technol Ther; 2016 Mar; 18(3):120-6. PubMed ID: 26950284
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.
Mráz M; Lacinová Z; Kaválková P; Haluzíková D; Trachta P; Drápalová J; Hanušová V; Haluzík M
Physiol Res; 2011; 60(4):627-36. PubMed ID: 21574752
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma/serum levels of prolactin in multiple sclerosis: a meta-analysis.
Wei W; Liu L; Cheng ZL; Hu B
Postgrad Med; 2017 Aug; 129(6):605-610. PubMed ID: 28120634
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus.
Li K; Li L; Yang M; Zong H; Liu H; Yang G
Eur J Endocrinol; 2009 Sep; 161(3):391-5. PubMed ID: 19528204
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 predicts the metabolic syndrome and type 2 diabetes in Caucasians.
Bobbert T; Schwarz F; Fischer-Rosinsky A; Pfeiffer AF; Möhlig M; Mai K; Spranger J
Diabetes Care; 2013 Jan; 36(1):145-9. PubMed ID: 22933429
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.
Zhu XW; Deng FY; Lei SF
Prim Care Diabetes; 2015 Feb; 9(1):60-7. PubMed ID: 24810146
[TBL] [Abstract][Full Text] [Related]
16. [Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes].
Zagarskikh EY; Proshchai GA; Vorokhobina NV
Urologiia; 2018 Mar; (1):92-95. PubMed ID: 29634140
[TBL] [Abstract][Full Text] [Related]
17. Mitiglinide treatment may decreases plasma fibroblast growth factor-21 levels in individuals with new-onset T2DM.
Wang B; Yang G; Yang M; Liao Y; Li Z; Boden G; Li L
Cytokine; 2012 Feb; 57(2):300-3. PubMed ID: 22129626
[TBL] [Abstract][Full Text] [Related]
18. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.
Chen WW; Li L; Yang GY; Li K; Qi XY; Zhu W; Tang Y; Liu H; Boden G
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):65-8. PubMed ID: 17926232
[TBL] [Abstract][Full Text] [Related]
19. Circulating Insulin-like Growth Factor-1 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis.
Zhao YL; Wu J; Zhang TP; Cheng QY; Wang XP; Gu MM; Pan HF; Ye DQ
Curr Pharm Des; 2019; 25(10):1091-1098. PubMed ID: 30892152
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines.
Reinehr T; Karges B; Meissner T; Wiegand S; Stoffel-Wagner B; Holl RW; Woelfle J
J Pediatr; 2016 Jun; 173():131-5. PubMed ID: 26996723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
